Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1299 entries
Sorted by: Best Match Show Resources per page
Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer.

Practical radiation oncology

Dholakia AS, Leal JP, Wild AT, Hacker-Prietz A, Chaudhry M, Diaz L, Wahl RL, Laheru D, Wolfgang CL, Herman JM.
PMID: 24674528
Pract Radiat Oncol. 2013 Apr-Jun;3(2):S26. doi: 10.1016/j.prro.2013.01.090. Epub 2013 Mar 25.

No abstract available.

Cite
Dholakia AS, Leal JP, Wild AT, et al. Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer. Pract Radiat Oncol. 2013;3(2):S26doi: 10.1016/j.prro.2013.01.090.
Dholakia, A. S., Leal, J. P., Wild, A. T., Hacker-Prietz, A., Chaudhry, M., Diaz, L., Wahl, R. L., Laheru, D., Wolfgang, C. L., & Herman, J. M. (2013). Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer. Practical radiation oncology, 3(2), S26. https://doi.org/10.1016/j.prro.2013.01.090
Dholakia, A S, et al. "Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer." Practical radiation oncology vol. 3,2 (2013): S26. doi: https://doi.org/10.1016/j.prro.2013.01.090
Dholakia AS, Leal JP, Wild AT, Hacker-Prietz A, Chaudhry M, Diaz L, Wahl RL, Laheru D, Wolfgang CL, Herman JM. Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer. Pract Radiat Oncol. 2013 Apr-Jun;3(2):S26. doi: 10.1016/j.prro.2013.01.090. Epub 2013 Mar 25. PMID: 24674528.
Copy Download .nbib Format: NLM
Giant Gastric Lipoma Presenting as Gastric Outlet Obstruction - A Case Report.

Journal of clinical and diagnostic research : JCDR

Priyadarshi RN, Anand U, Pandey MK, Chaudhary B, Kumar R.
PMID: 26557564
J Clin Diagn Res. 2015 Oct;9(10):PD03-4. doi: 10.7860/JCDR/2015/14816.6595. Epub 2015 Oct 01.

Gartric lipomas are rare. They are mostly small in size, and usually remain asymptomatic. We report a case of giant (14×11cm) gastric lipoma in a 46-year-old male who presented with features of gastric outlet obstruction clinically mimicking gastric malignancy....

Cite
Priyadarshi RN, Anand U, Pandey MK, et al. Giant Gastric Lipoma Presenting as Gastric Outlet Obstruction - A Case Report. J Clin Diagn Res. 2015;9(10):PD03-4doi: 10.7860/JCDR/2015/14816.6595.
Priyadarshi, R. N., Anand, U., Pandey, M. K., Chaudhary, B., & Kumar, R. (2015). Giant Gastric Lipoma Presenting as Gastric Outlet Obstruction - A Case Report. Journal of clinical and diagnostic research : JCDR, 9(10), PD03-4. https://doi.org/10.7860/JCDR/2015/14816.6595
Priyadarshi, Rajeev Nayan, et al. "Giant Gastric Lipoma Presenting as Gastric Outlet Obstruction - A Case Report." Journal of clinical and diagnostic research : JCDR vol. 9,10 (2015): PD03-4. doi: https://doi.org/10.7860/JCDR/2015/14816.6595
Priyadarshi RN, Anand U, Pandey MK, Chaudhary B, Kumar R. Giant Gastric Lipoma Presenting as Gastric Outlet Obstruction - A Case Report. J Clin Diagn Res. 2015 Oct;9(10):PD03-4. doi: 10.7860/JCDR/2015/14816.6595. Epub 2015 Oct 01. PMID: 26557564; PMCID: PMC4625283.
Copy Download .nbib Format: NLM
Can community-based, low-cost antenatal care in the third trimester of pregnancy reduce the incidence of low birth weight newborns?.

Journal of obstetrics and gynaecology of India

Chaudhary AK, Chaudhary A, Tiwari SC, Dwivedi R.
PMID: 23730031
J Obstet Gynaecol India. 2012 Jun;62(3):286-90. doi: 10.1007/s13224-012-0217-x. Epub 2012 Aug 17.

OBJECTIVE: To determine if community-based, low-cost interventions during third trimester of pregnancy can reduce the incidence of low birth weight babies.METHODS: In a case control study, 290 pregnant women from a slum area were registered in the beginning of...

Cite
Chaudhary AK, Chaudhary A, Tiwari SC, et al. Can community-based, low-cost antenatal care in the third trimester of pregnancy reduce the incidence of low birth weight newborns?. J Obstet Gynaecol India. 2012;62(3):286-90doi: 10.1007/s13224-012-0217-x.
Chaudhary, A. K., Chaudhary, A., Tiwari, S. C., & Dwivedi, R. (2012). Can community-based, low-cost antenatal care in the third trimester of pregnancy reduce the incidence of low birth weight newborns?. Journal of obstetrics and gynaecology of India, 62(3), 286-90. https://doi.org/10.1007/s13224-012-0217-x
Chaudhary, A K, et al. "Can community-based, low-cost antenatal care in the third trimester of pregnancy reduce the incidence of low birth weight newborns?." Journal of obstetrics and gynaecology of India vol. 62,3 (2012): 286-90. doi: https://doi.org/10.1007/s13224-012-0217-x
Chaudhary AK, Chaudhary A, Tiwari SC, Dwivedi R. Can community-based, low-cost antenatal care in the third trimester of pregnancy reduce the incidence of low birth weight newborns?. J Obstet Gynaecol India. 2012 Jun;62(3):286-90. doi: 10.1007/s13224-012-0217-x. Epub 2012 Aug 17. PMID: 23730031; PMCID: PMC3444561.
Copy Download .nbib Format: NLM
Reversible cerebral and brain stem dysfunction in n: Hexane neuropathy.

Annals of Indian Academy of Neurology

Puri V, Gupta AD, Chaudhry N, Saran RK.
PMID: 26713026
Ann Indian Acad Neurol. 2015 Oct-Dec;18(4):464-7. doi: 10.4103/0972-2327.160088.

A 18-year-old male, screen printer by profession developed sensory motor polyneuropathy, change in his behavior, bilateral 6(th) and 7(th) cranial nerve palsies, down beat nystagmus and cerebellar dysarthria. He had bilaterally prolonged P100 latency; left: 137 ms; right: 144...

Cite
Puri V, Gupta AD, Chaudhry N, et al. Reversible cerebral and brain stem dysfunction in n: Hexane neuropathy. Ann Indian Acad Neurol. 2015;18(4):464-7doi: 10.4103/0972-2327.160088.
Puri, V., Gupta, A. D., Chaudhry, N., & Saran, R. K. (2015). Reversible cerebral and brain stem dysfunction in n: Hexane neuropathy. Annals of Indian Academy of Neurology, 18(4), 464-7. https://doi.org/10.4103/0972-2327.160088
Puri, Vinod, et al. "Reversible cerebral and brain stem dysfunction in n: Hexane neuropathy." Annals of Indian Academy of Neurology vol. 18,4 (2015): 464-7. doi: https://doi.org/10.4103/0972-2327.160088
Puri V, Gupta AD, Chaudhry N, Saran RK. Reversible cerebral and brain stem dysfunction in n: Hexane neuropathy. Ann Indian Acad Neurol. 2015 Oct-Dec;18(4):464-7. doi: 10.4103/0972-2327.160088. PMID: 26713026; PMCID: PMC4683893.
Copy Download .nbib Format: NLM
The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study.

Journal of maxillofacial and oral surgery

Chaudhry Z, Gupta SR, Oberoi SS.
PMID: 25018602
J Maxillofac Oral Surg. 2014 Sep;13(3):286-94. doi: 10.1007/s12663-013-0511-x. Epub 2013 Apr 18.

INTRODUCTION: Oral submucous fibrosis (OSMF) is a chronic insidious disease mainly associated with fibroelastic change of the oral mucous membrane, leading to progressive trismus and oral burning sensation. The management of OSMF is empirical, depends on staging of the...

Cite
Chaudhry Z, Gupta SR, Oberoi SS. The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study. J Maxillofac Oral Surg. 2013;13(3):286-94doi: 10.1007/s12663-013-0511-x.
Chaudhry, Z., Gupta, S. R., & Oberoi, S. S. (2014). The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study. Journal of maxillofacial and oral surgery, 13(3), 286-94. https://doi.org/10.1007/s12663-013-0511-x
Chaudhry, Zainab, et al. "The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study." Journal of maxillofacial and oral surgery vol. 13,3 (2014): 286-94. doi: https://doi.org/10.1007/s12663-013-0511-x
Chaudhry Z, Gupta SR, Oberoi SS. The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study. J Maxillofac Oral Surg. 2014 Sep;13(3):286-94. doi: 10.1007/s12663-013-0511-x. Epub 2013 Apr 18. PMID: 25018602; PMCID: PMC4082553.
Copy Download .nbib Format: NLM
A uniform measurement expression for cross method comparison of nanoparticle aggregate size distributions.

The Analyst

Dudkiewicz A, Wagner S, Lehner A, Chaudhry Q, Pietravalle S, Tiede K, Boxall AB, Allmaier G, Tiede D, Grombe R, von der Kammer F, Hofmann T, Mølhave K.
PMID: 26081166
Analyst. 2015 Aug 07;140(15):5257-67. doi: 10.1039/c5an00561b.

Available measurement methods for nanomaterials are based on very different measurement principles and hence produce different values when used on aggregated nanoparticle dispersions. This paper provides a solution for relating measurements of nanomaterials comprised of nanoparticle aggregates determined by...

Cite
Dudkiewicz A, Wagner S, Lehner A, et al. A uniform measurement expression for cross method comparison of nanoparticle aggregate size distributions. Analyst. 2015;140(15):5257-67doi: 10.1039/c5an00561b.
Dudkiewicz, A., Wagner, S., Lehner, A., Chaudhry, Q., Pietravalle, S., Tiede, K., Boxall, A. B., Allmaier, G., Tiede, D., Grombe, R., von der Kammer, F., Hofmann, T., & Mølhave, K. (2015). A uniform measurement expression for cross method comparison of nanoparticle aggregate size distributions. The Analyst, 140(15), 5257-67. https://doi.org/10.1039/c5an00561b
Dudkiewicz, Agnieszka, et al. "A uniform measurement expression for cross method comparison of nanoparticle aggregate size distributions." The Analyst vol. 140,15 (2015): 5257-67. doi: https://doi.org/10.1039/c5an00561b
Dudkiewicz A, Wagner S, Lehner A, Chaudhry Q, Pietravalle S, Tiede K, Boxall AB, Allmaier G, Tiede D, Grombe R, von der Kammer F, Hofmann T, Mølhave K. A uniform measurement expression for cross method comparison of nanoparticle aggregate size distributions. Analyst. 2015 Aug 07;140(15):5257-67. doi: 10.1039/c5an00561b. PMID: 26081166.
Copy Download .nbib Format: NLM
Bilateral Sagittal Split Osteotomy Without Rigid Fixation: Is It A More Physiologic Option?.

The Journal of craniofacial surgery

Chaudhary D, Sharma R.
PMID: 26079126
J Craniofac Surg. 2015 Jul;26(5):e457-8. doi: 10.1097/SCS.0000000000001648.

No abstract available.

Cite
Chaudhary D, Sharma R. Bilateral Sagittal Split Osteotomy Without Rigid Fixation: Is It A More Physiologic Option?. J Craniofac Surg. 2015;26(5):e457-8doi: 10.1097/SCS.0000000000001648.
Chaudhary, D., & Sharma, R. (2015). Bilateral Sagittal Split Osteotomy Without Rigid Fixation: Is It A More Physiologic Option?. The Journal of craniofacial surgery, 26(5), e457-8. https://doi.org/10.1097/SCS.0000000000001648
Chaudhary, Dinesh, and Sharma, Rohit. "Bilateral Sagittal Split Osteotomy Without Rigid Fixation: Is It A More Physiologic Option?." The Journal of craniofacial surgery vol. 26,5 (2015): e457-8. doi: https://doi.org/10.1097/SCS.0000000000001648
Chaudhary D, Sharma R. Bilateral Sagittal Split Osteotomy Without Rigid Fixation: Is It A More Physiologic Option?. J Craniofac Surg. 2015 Jul;26(5):e457-8. doi: 10.1097/SCS.0000000000001648. PMID: 26079126.
Copy Download .nbib Format: NLM
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting.

Vaccines

Chaudhary B, Elkord E.
PMID: 27509527
Vaccines (Basel). 2016 Aug 06;4(3). doi: 10.3390/vaccines4030028.

Recent years have seen significant efforts in understanding and modulating the immune response in cancer. In this context, immunosuppressive cells, including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), have come under intense investigation for their proposed roles...

Cite
Chaudhary B, Elkord E. Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel). 2016;4(3)doi: 10.3390/vaccines4030028.
Chaudhary, B., & Elkord, E. (2016). Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines, 4(3), . https://doi.org/10.3390/vaccines4030028
Chaudhary, Belal, and Elkord, Eyad. "Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting." Vaccines vol. 4,3 (2016). doi: https://doi.org/10.3390/vaccines4030028
Chaudhary B, Elkord E. Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel). 2016 Aug 06;4(3). doi: 10.3390/vaccines4030028. PMID: 27509527; PMCID: PMC5041022.
Copy Download .nbib Format: NLM
Graphene-Nanodiamond Heterostructures and their application to High Current Devices.

Scientific reports

Zhao F, Vrajitoarea A, Jiang Q, Han X, Chaudhary A, Welch JO, Jackman RB.
PMID: 26350107
Sci Rep. 2015 Sep 09;5:13771. doi: 10.1038/srep13771.

Graphene on hydrogen terminated monolayer nanodiamond heterostructures provides a new way to improve carrier transport characteristics of the graphene, offering up to 60% improvement when compared with similar graphene on SiO2/Si substrates. These heterostructures offers excellent current-carrying abilities whilst...

Cite
Zhao F, Vrajitoarea A, Jiang Q, et al. Graphene-Nanodiamond Heterostructures and their application to High Current Devices. Sci Rep. 2015;5:13771doi: 10.1038/srep13771.
Zhao, F., Vrajitoarea, A., Jiang, Q., Han, X., Chaudhary, A., Welch, J. O., & Jackman, R. B. (2015). Graphene-Nanodiamond Heterostructures and their application to High Current Devices. Scientific reports, 513771. https://doi.org/10.1038/srep13771
Zhao, Fang, et al. "Graphene-Nanodiamond Heterostructures and their application to High Current Devices." Scientific reports vol. 5 (2015): 13771. doi: https://doi.org/10.1038/srep13771
Zhao F, Vrajitoarea A, Jiang Q, Han X, Chaudhary A, Welch JO, Jackman RB. Graphene-Nanodiamond Heterostructures and their application to High Current Devices. Sci Rep. 2015 Sep 09;5:13771. doi: 10.1038/srep13771. PMID: 26350107; PMCID: PMC4563554.
Copy Download .nbib Format: NLM
Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy.

Scientific reports

Liu J, Tian J, Chaudhry M, Maxwell K, Yan Y, Wang X, Shah PT, Khawaja AA, Martin R, Robinette TJ, El-Hamdani A, Dodrill MW, Sodhi K, Drummond CA, Haller ST, Kennedy DJ, Abraham NG, Xie Z, Shapiro JI.
PMID: 29052587
Sci Rep. 2017 Oct 20;7:46893. doi: 10.1038/srep46893.

This corrects the article DOI: 10.1038/srep34592.

Cite
Liu J, Tian J, Chaudhry M, et al. Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy. Sci Rep. 2017;7:46893doi: 10.1038/srep46893.
Liu, J., Tian, J., Chaudhry, M., Maxwell, K., Yan, Y., Wang, X., Shah, P. T., Khawaja, A. A., Martin, R., Robinette, T. J., El-Hamdani, A., Dodrill, M. W., Sodhi, K., Drummond, C. A., Haller, S. T., Kennedy, D. J., Abraham, N. G., Xie, Z., & Shapiro, J. I. (2017). Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy. Scientific reports, 746893. https://doi.org/10.1038/srep46893
Liu, Jiang, et al. "Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy." Scientific reports vol. 7 (2017): 46893. doi: https://doi.org/10.1038/srep46893
Liu J, Tian J, Chaudhry M, Maxwell K, Yan Y, Wang X, Shah PT, Khawaja AA, Martin R, Robinette TJ, El-Hamdani A, Dodrill MW, Sodhi K, Drummond CA, Haller ST, Kennedy DJ, Abraham NG, Xie Z, Shapiro JI. Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy. Sci Rep. 2017 Oct 20;7:46893. doi: 10.1038/srep46893. PMID: 29052587; PMCID: PMC5649217.
Copy Download .nbib Format: NLM
Characterization of cytopathogenicity of classical swine fever virus isolate induced by Newcastle disease virus.

Virusdisease

Raut SD, Rajak KK, Kumar R, Singh VK, Saxena A, Chaudhary D, Muthuchelvan D, Pandey AB.
PMID: 26436124
Virusdisease. 2015 Jun;26(1):70-6. doi: 10.1007/s13337-015-0253-0. Epub 2015 May 23.

Classical swine fever virus (CSFV), the causative agent of classical swine fever, belongs to the family Flaviviridae and genus Pestivirus. Some pestiviruses exhibit cytopathic effect in cell culture but exact phenomenon is unknown. Over expression of NS2-3 gene, presence...

Cite
Raut SD, Rajak KK, Kumar R, et al. Characterization of cytopathogenicity of classical swine fever virus isolate induced by Newcastle disease virus. Virusdisease. 2015;26(1):70-6doi: 10.1007/s13337-015-0253-0.
Raut, S. D., Rajak, K. K., Kumar, R., Singh, V. K., Saxena, A., Chaudhary, D., Muthuchelvan, D., & Pandey, A. B. (2015). Characterization of cytopathogenicity of classical swine fever virus isolate induced by Newcastle disease virus. Virusdisease, 26(1), 70-6. https://doi.org/10.1007/s13337-015-0253-0
Raut, S D, et al. "Characterization of cytopathogenicity of classical swine fever virus isolate induced by Newcastle disease virus." Virusdisease vol. 26,1 (2015): 70-6. doi: https://doi.org/10.1007/s13337-015-0253-0
Raut SD, Rajak KK, Kumar R, Singh VK, Saxena A, Chaudhary D, Muthuchelvan D, Pandey AB. Characterization of cytopathogenicity of classical swine fever virus isolate induced by Newcastle disease virus. Virusdisease. 2015 Jun;26(1):70-6. doi: 10.1007/s13337-015-0253-0. Epub 2015 May 23. PMID: 26436124; PMCID: PMC4585056.
Copy Download .nbib Format: NLM
Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer.

ACS medicinal chemistry letters

Zhang Y, Seigal BA, Terrett NK, Talbott RL, Fargnoli J, Naglich JG, Chaudhry C, Posy SL, Vuppugalla R, Cornelius G, Lei M, Wang C, Zhang Y, Schmidt RJ, Wei DD, Miller MM, Allen MP, Li L, Carter PH, Vite GD, Borzilleri RM.
PMID: 26191364
ACS Med Chem Lett. 2015 May 27;6(7):770-5. doi: 10.1021/acsmedchemlett.5b00091. eCollection 2015 Jul 09.

A series of dimeric macrocyclic compounds were prepared and evaluated as antagonists for inhibitor of apoptosis proteins. The most potent analogue 11, which binds to XIAP and c-IAP proteins with high affinity and induces caspase-3 activation and ultimately cell...

Cite
Zhang Y, Seigal BA, Terrett NK, et al. Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer. ACS Med Chem Lett. 2015;6(7):770-5doi: 10.1021/acsmedchemlett.5b00091.
Zhang, Y., Seigal, B. A., Terrett, N. K., Talbott, R. L., Fargnoli, J., Naglich, J. G., Chaudhry, C., Posy, S. L., Vuppugalla, R., Cornelius, G., Lei, M., Wang, C., Zhang, Y., Schmidt, R. J., Wei, D. D., Miller, M. M., Allen, M. P., Li, L., Carter, P. H., Vite, G. D., & Borzilleri, R. M. (2015). Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer. ACS medicinal chemistry letters, 6(7), 770-5. https://doi.org/10.1021/acsmedchemlett.5b00091
Zhang, Yong, et al. "Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer." ACS medicinal chemistry letters vol. 6,7 (2015): 770-5. doi: https://doi.org/10.1021/acsmedchemlett.5b00091
Zhang Y, Seigal BA, Terrett NK, Talbott RL, Fargnoli J, Naglich JG, Chaudhry C, Posy SL, Vuppugalla R, Cornelius G, Lei M, Wang C, Zhang Y, Schmidt RJ, Wei DD, Miller MM, Allen MP, Li L, Carter PH, Vite GD, Borzilleri RM. Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer. ACS Med Chem Lett. 2015 May 27;6(7):770-5. doi: 10.1021/acsmedchemlett.5b00091. eCollection 2015 Jul 09. PMID: 26191364; PMCID: PMC4499820.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1299 entries